173 related articles for article (PubMed ID: 25895729)
21. A microneedle roller for transdermal drug delivery.
Park JH; Choi SO; Seo S; Choy YB; Prausnitz MR
Eur J Pharm Biopharm; 2010 Oct; 76(2):282-9. PubMed ID: 20624460
[TBL] [Abstract][Full Text] [Related]
22. Estimation of skin concentrations of topically applied lidocaine at each depth profile.
Oshizaka T; Kikuchi K; Kadhum WR; Todo H; Hatanaka T; Wierzba K; Sugibayashi K
Int J Pharm; 2014 Nov; 475(1-2):292-7. PubMed ID: 25158219
[TBL] [Abstract][Full Text] [Related]
23. Intradermal Delivery of an Immunomodulator for Basal Cell Carcinoma; Expanding the Mechanistic Insight into Solid Microneedle-Enhanced Delivery of Hydrophobic Molecules.
Sabri A; Ogilvie J; McKenna J; Segal J; Scurr D; Marlow M
Mol Pharm; 2020 Aug; 17(8):2925-2937. PubMed ID: 32510228
[TBL] [Abstract][Full Text] [Related]
24. An alternative lidocaine hydrochloride liposomal gel formulation: preparation, percutaneous permeation, and release kinetics.
Gong JH; Liu Y; Tang LH; Xu XJ; Zhang XN
PDA J Pharm Sci Technol; 2006; 60(4):259-63. PubMed ID: 17089695
[TBL] [Abstract][Full Text] [Related]
25. Effect of force of microneedle insertion on the permeability of insulin in skin.
Cheung K; Han T; Das DB
J Diabetes Sci Technol; 2014 May; 8(3):444-52. PubMed ID: 24876604
[TBL] [Abstract][Full Text] [Related]
26. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
[TBL] [Abstract][Full Text] [Related]
27. Effect of microneedles on transdermal permeation enhancement of amlodipine.
Nalluri BN; Uppuluri C; Devineni J; Nayak A; Nair KJ; Whiteside BR; Das DB
Drug Deliv Transl Res; 2017 Jun; 7(3):383-394. PubMed ID: 28160258
[TBL] [Abstract][Full Text] [Related]
28. Microneedle mediated delivery of nanoparticles into human skin.
Coulman SA; Anstey A; Gateley C; Morrissey A; McLoughlin P; Allender C; Birchall JC
Int J Pharm; 2009 Jan; 366(1-2):190-200. PubMed ID: 18812218
[TBL] [Abstract][Full Text] [Related]
29. Impact of Formulation and Microneedle Length on Transdermal Metronidazole Permeation through Microneedle-Treated Skin.
Patel KK; Brogden NK
Pharm Res; 2024 Feb; 41(2):355-363. PubMed ID: 38133717
[TBL] [Abstract][Full Text] [Related]
30. Lidocaine self-sacrificially improves the skin permeation of the acidic and poorly water-soluble drug etodolac via its transformation into an ionic liquid.
Miwa Y; Hamamoto H; Ishida T
Eur J Pharm Biopharm; 2016 May; 102():92-100. PubMed ID: 26945484
[TBL] [Abstract][Full Text] [Related]
31. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
Xie Y; Xu B; Gao Y
Nanomedicine; 2005 Jun; 1(2):184-90. PubMed ID: 17292077
[TBL] [Abstract][Full Text] [Related]
32. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
33. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
Singh S; Gajra B; Rawat M; Muthu MS
Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
[TBL] [Abstract][Full Text] [Related]
34. Effective permeation of 2.5 and 5% lidocaine hydrochloride in human skin using iontophoresis technique.
Manjunatha RG; Sharma S; Narayan RP; Koul V
Int J Dermatol; 2018 Nov; 57(11):1335-1343. PubMed ID: 29978889
[TBL] [Abstract][Full Text] [Related]
35. Full-Thickness Intraoral Mucosa Barrier Models for In Vitro Drug-Permeation Studies Using Microneedles.
Serpe L; Muniz BV; Santos CPD; da Silva CB; Volpato MC; Groppo FC; Lopez RFV; Franz-Montan M
J Pharm Sci; 2019 May; 108(5):1756-1764. PubMed ID: 30553821
[TBL] [Abstract][Full Text] [Related]
36. Qualitative and quantitative analysis of lateral diffusion of drugs in human skin.
Nguyen HX; Puri A; Bhattaccharjee SA; Banga AK
Int J Pharm; 2018 Jun; 544(1):62-74. PubMed ID: 29654897
[TBL] [Abstract][Full Text] [Related]
37. Flux of ionic dyes across microneedle-treated skin: effect of molecular characteristics.
Gomaa YA; Garland MJ; McInnes FJ; Donnelly RF; El-Khordagui LK; Wilson CG
Int J Pharm; 2012 Nov; 438(1-2):140-9. PubMed ID: 22960319
[TBL] [Abstract][Full Text] [Related]
38. Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration.
McGrath MG; Vucen S; Vrdoljak A; Kelly A; O'Mahony C; Crean AM; Moore A
Eur J Pharm Biopharm; 2014 Feb; 86(2):200-11. PubMed ID: 23727511
[TBL] [Abstract][Full Text] [Related]
39. Bacterial cellulose membranes applied in topical and transdermal delivery of lidocaine hydrochloride and ibuprofen: in vitro diffusion studies.
Trovatti E; Freire CS; Pinto PC; Almeida IF; Costa P; Silvestre AJ; Neto CP; Rosado C
Int J Pharm; 2012 Oct; 435(1):83-7. PubMed ID: 22266531
[TBL] [Abstract][Full Text] [Related]
40. The role of subcutaneous tissue stiffness on microneedle performance in a representative in vitro model of skin.
Moronkeji K; Todd S; Dawidowska I; Barrett SD; Akhtar R
J Control Release; 2017 Nov; 265():102-112. PubMed ID: 27838272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
